Ya-Ting Lei

@LeiYating

Biotech strategic marketer and business development leader. Believer in Science 🧬 Driving CDx in the APAC region 💊

Singapore
Vrijeme pridruživanja: veljača 2016.

Tweetovi

Blokirali ste korisnika/cu @LeiYating

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LeiYating

  1. proslijedio/la je Tweet

    Wuhan Coronavirus: Scientists in Singapore culture virus from patient. Exemplary work by LinFa WANG and colleagues in 🇸🇬. It takes a village! See thread👇 1/n S’pore only third country to isolate virus from patient sample. Infrastructure investment

    Prikaži ovu nit
    Poništi
  2. 2. velj
    Poništi
  3. proslijedio/la je Tweet

    New report from China on epidemic: Cumulative total of 14,380 confirmed cases, 304 deaths and 19,544 suspected cases. These grim totals suggest a slowing in acceleration relative to recent day-over-day reporting, but caution that totals heavily influenced by testing parameters.

    Prikaži ovu nit
    Poništi
  4. 1. velj
    Poništi
  5. 23. stu 2019.
    Poništi
  6. proslijedio/la je Tweet

    Many cancers go undetected until late stages. Learn more about how we are striving to change the trajectory of cancer mortality and transform cancer care through early detection

    Poništi
  7. proslijedio/la je Tweet
    13. stu 2019.

    A note from the Illumina Chief Medical Officer Phil Febbo on the promise of liquid biopsy assays and how they might be able help cancer patients. No wonder we are excited about our new assay TruSight Oncology 500 ctDNA!

    Poništi
  8. proslijedio/la je Tweet
    14. stu 2019.

    Altogether, we find that if similar nations fund PopSeq projects similarly to what's been established, the annual spend on PopSeq could grow from ~$1.5B/year to ~$4.5B/year, eclipsing the size of the current sequencing industry as it stands today.

    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    25. lis 2019.
    Poništi
  10. 26. lis 2019.

    First Phase III cancer study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer

    Poništi
  11. proslijedio/la je Tweet
    24. lis 2019.

    Hoping the guideline is cell-free screening for all.

    Poništi
  12. proslijedio/la je Tweet
    17. lis 2019.

    Did you know that genomics is helping crack the code of common neurological disorders? See how:

    Poništi
  13. 16. lis 2019.

    This is a common dilemma that many couples are facing in the modern society....

    Poništi
  14. 16. lis 2019.
    Poništi
  15. proslijedio/la je Tweet

    Yesterday, marathoner Eliud Kipchoge became the first ever to break two hours. Today in Chicago, Brigid Kosgei set a new women’s world record. Staggering achievements on their own, they’re also remarkable examples of humanity’s ability to endure—and keep raising the bar.

    Poništi
  16. proslijedio/la je Tweet

    We are excited to announce positive validation data from our foundational CCGA study on an independent data set will be presented at ASCO Breakthrough in Bangkok.

    Poništi
  17. proslijedio/la je Tweet

    China's one-child policy will have a far-reaching impact on its society for years to come

    Poništi
  18. proslijedio/la je Tweet
    8. ruj 2019.

    Rossa Chiu gave a brilliant talk on using differential cutting of plasma cell-free DNA to determine tissue of origin. She ended with a vision of the future “fragmentomics-stay tuned.”

    Poništi
  19. proslijedio/la je Tweet

    Biomarker testing can also reveal “tumor-agnostic” genomic alterations, like NTRK gene fusions. These are associated with many cancers, including breast, colorectal, gynecological, non-small cell lung, pancreatic and thyroid.

    Prikaži ovu nit
    Poništi
  20. 17. kol 2019.

    Rozlytrek (entrectinib) is the first FDA-approved treatment that selectively targets both ROS1 and NTRK fusions. It has also shown responses in these rare cancer types that have spread to the brain.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·